AstraZeneca's treatment for adults with muscle-invasive bladder cancer was approved in the U.S.

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Learn the 7 vital bladder cancer warning signs that require immediate medical attention, including subtle early symptoms many ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

ABOUT 55,000 new prostate cancer cases are recorded every year in the UK. Bladder cancer is less common, with around 10,500 ...

Urinary retention is a common condition in men characterised by the inability to fully empty the bladder despite the urge to ...

British Army bomb disposal veterans may face a five-times higher risk of developing bladder cancer, researchers suggest. A ...

The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in ...

Eddie Jordan, the Formula 1 legend, died on Thursday in Cape Town, South Africa following a journey with bladder cancer, ...

Bladder cancer spreads at different speeds depending on the type of bladder cancer you have. Urothelial bladder cancer is slow to spread, while other types are much faster. Urothelial bladder ...

Symptoms of prostate cancer may include needing to urinate more frequently; having to rush to the toilet; straining to ...

AstraZeneca’s Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy after radical cystectomy (surgery to remove the ...